Funding Rounds
AATec Medical

AATec Medical Seed (2023, $2M)

AATec Medical

Product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $2.70M